Literature DB >> 8621177

Severe recurrent cholestatic hepatitis C following orthotopic liver transplantation.

L K Schluger1, P A Sheiner, S N Thung, J Y Lau, A Min, D C Wolf, I Fiel, D Zhang, M A Gerber, C M Miller, H C Bodenheimer.   

Abstract

Recurrent infection with hepatitis C virus (HCV) is almost universal following orthotopic liver transplantation although clinical severity varies. Data on 135 patients who underwent transplantation for hepatitis C cirrhosis were reviewed. We describe a progressive, severe cholestatic form of hepatitis occurring in a subgroup of patients with recurrent hepatitis C. Ten patients with severe recurrent hepatitis C were identified; 1 has died, 1 awaits retransplantation, and 8 have undergone retransplantation. All 10 developed severe progressive cholestatic hepatitis, with a mean rise in bilirubin to 24.7 mg/dL at the time of retransplantation. Histology at initial recurrence was of mild hepatitis without evidence of rejection. The failed grafts showed either cirrhosis or confluent hepatic necrosis. The onset of cholestasis preceded retransplantation by less than 5 months. Our study suggests that a minority of patients with recurrent hepatitis C after undergoing liver transplantation develop a severe progressive cholestatic hepatitis and liver failure.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8621177     DOI: 10.1002/hep.510230505

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  40 in total

Review 1.  Hepatitis C and liver transplantation.

Authors:  M Berenguer; T L Wright
Journal:  Gut       Date:  1999-08       Impact factor: 23.059

2.  Long term outcome of liver transplantation for viral hepatitis: is there a need to re-evaluate patient selection?

Authors:  D Mutimer
Journal:  Gut       Date:  1999-10       Impact factor: 23.059

Review 3.  Treatment of recurrent hepatitis C following liver transplantation.

Authors:  T Bizollon; C Ducerf; J Baulieux; C Trepo
Journal:  Curr Gastroenterol Rep       Date:  1999 Feb-Mar

4.  Early diagnosis and treatment resolved cholestatic hepatitis C without fibrosis after living donor liver transplantation: report of a case.

Authors:  Takasuke Fukuhara; Kazutoyo Morita; Kazuki Takeishi; Takeo Toshima; Kenji Umeda; Shigeyuki Nagata; Keishi Sugimachi; Toru Ikegami; Tomonobu Gion; Yuji Soejima; Akinobu Taketomi; Yoshihiko Maehara
Journal:  Surg Today       Date:  2010-09-25       Impact factor: 2.549

Review 5.  Histopathological evaluation of recurrent hepatitis C after liver transplantation: a review.

Authors:  Francesco Vasuri; Deborah Malvi; Elisa Gruppioni; Walter F Grigioni; Antonia D'Errico-Grigioni
Journal:  World J Gastroenterol       Date:  2014-03-21       Impact factor: 5.742

Review 6.  Mechanisms of hepatic fibrogenesis.

Authors:  Scott L Friedman
Journal:  Gastroenterology       Date:  2008-05       Impact factor: 22.682

Review 7.  What is expected from the pathologist in the diagnosis of viral hepatitis?

Authors:  Helmut Denk
Journal:  Virchows Arch       Date:  2011-02-26       Impact factor: 4.064

Review 8.  The role of purinergic signaling in the liver and in transplantation: effects of extracellular nucleotides on hepatic graft vascular injury, rejection and metabolism.

Authors:  Guido Beldi; Keiichi Enjyoji; Yan Wu; Lindsay Miller; Yara Banz; Xiaofeng Sun; Simon C Robson
Journal:  Front Biosci       Date:  2008-01-01

Review 9.  Hepatic regeneration and the epithelial to mesenchymal transition.

Authors:  Zeng-Fu Xue; Xiu-Min Wu; Ming Liu
Journal:  World J Gastroenterol       Date:  2013-03-07       Impact factor: 5.742

10.  Clinical outcome of patients infected with hepatitis C virus infection on survival after primary liver transplantation under tacrolimus.

Authors:  F A Casavilla; J Rakela; S Kapur; W Irish; J McMichael; A J Demetris; T E Starzl; J J Fung
Journal:  Liver Transpl Surg       Date:  1998-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.